One of the main biotechs hoping to capitalize on the powerful gene-editing system called Crispr-Cas9 is squatting on the Twitter handles most directly associated with the technology.
The post The Battle Over Crispr Rights Is Playing Out on Twitter Too appeared first on WIRED.
